Published in J Rheumatol on May 01, 2001
Helicobacter pylori and autoimmune disease: cause or bystander. World J Gastroenterol (2014) 0.97
Helicobacter pylori and autoimmune diseases. Oral Dis (2011) 0.86
Role of Helicobacter pylori infection in autoimmune systemic rheumatic diseases. World J Gastroenterol (2014) 0.77
A comparison of five maintenance therapies for reflux esophagitis. N Engl J Med (1995) 3.98
Safety of low dose glucocorticoid treatment in rheumatoid arthritis: published evidence and prospective trial data. Ann Rheum Dis (2005) 2.48
Reflux pattern and role of impedance-pH variables in predicting PPI response in patients with suspected GERD-related chronic cough. Aliment Pharmacol Ther (2014) 2.27
Hypothalamic-pituitary-adrenocortical axis function in premenopausal women with rheumatoid arthritis not treated with glucocorticoids. J Rheumatol (1999) 2.08
Anti-inflammatory mechanisms of methotrexate in rheumatoid arthritis. Ann Rheum Dis (2001) 1.95
EULAR evidence-based recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases. Ann Rheum Dis (2007) 1.90
Standardised nomenclature for glucocorticoid dosages and glucocorticoid treatment regimens: current questions and tentative answers in rheumatology. Ann Rheum Dis (2002) 1.85
Synovial fluid from patients with rheumatoid arthritis inhibits neutrophil apoptosis: role of adenosine and proinflammatory cytokines. Rheumatology (Oxford) (2002) 1.82
Are clinical patterns of dyspepsia a valid guideline for appropriate use of endoscopy? A report on 2253 dyspeptic patients. Am J Gastroenterol (1993) 1.74
Preliminary criteria for the very early diagnosis of systemic sclerosis: results of a Delphi Consensus Study from EULAR Scleroderma Trials and Research Group. Ann Rheum Dis (2010) 1.73
Sex hormones influence on the immune system: basic and clinical aspects in autoimmunity. Lupus (2004) 1.73
Estrogens, the immune response and autoimmunity. Clin Exp Rheumatol (1995) 1.60
Differential expression of the ED sequence-containing form of cellular fibronectin in embryonic and adult human tissues. J Cell Sci (1987) 1.60
Energy regulation and neuroendocrine-immune control in chronic inflammatory diseases. J Intern Med (2010) 1.54
Esomeprazole 20 mg and lansoprazole 15 mg in maintaining healed reflux oesophagitis: Metropole study results. Aliment Pharmacol Ther (2003) 1.52
Comparison of isotope ratio mass spectrometry and nondispersive isotope-selective infrared spectroscopy for 13C-urea breath test. Am J Gastroenterol (1999) 1.50
Circannual vitamin d serum levels and disease activity in rheumatoid arthritis: Northern versus Southern Europe. Clin Exp Rheumatol (2007) 1.49
Pathophysiological characteristics of patients with non-erosive reflux disease differ from those of patients with functional heartburn. Aliment Pharmacol Ther (2004) 1.49
Functional heartburn has more in common with functional dyspepsia than with non-erosive reflux disease. Gut (2009) 1.49
Circadian rhythms in RA. Ann Rheum Dis (2003) 1.47
Involvement of the hypothalamic--pituitary--adrenal/gonadal axis and the peripheral nervous system in rheumatoid arthritis: viewpoint based on a systemic pathogenetic role. Arthritis Rheum (2001) 1.46
Are duodenal ulcer seasonal fluctuations paralleled by seasonal changes in 24-hour gastric acidity and Helicobacter pylori infection? J Clin Gastroenterol (1996) 1.44
Circadian pattern of intragastric acidity in patients with non-erosive reflux disease (NERD). Aliment Pharmacol Ther (2003) 1.44
Pathophysiological characteristics of the various forms of gastro-oesophageal reflux disease. Spectrum disease or distinct phenotypic presentations? Dig Liver Dis (2006) 1.42
H2 antagonist and omeprazole nonresponders. Dig Dis Sci (1991) 1.39
Current evidence for the management of rheumatoid arthritis with glucocorticoids: a systematic literature review informing the EULAR recommendations for the management of rheumatoid arthritis. Ann Rheum Dis (2010) 1.38
Histological and functional recovery in patients with multifocal atrophic gastritis after eradication of Helicobacter pylori infection. Ital J Gastroenterol Hepatol (1999) 1.38
Nailfold videocapillaroscopic patterns and serum autoantibodies in systemic sclerosis. Rheumatology (Oxford) (2004) 1.35
Altered circadian rhythms in rheumatoid arthritis patients play a role in the disease's symptoms. Autoimmun Rev (2005) 1.28
Normal values of 24-h ambulatory intraluminal impedance combined with pH-metry in subjects eating a Mediterranean diet. Dig Liver Dis (2006) 1.26
Vitamin D and autoimmune rheumatic diseases. Rheumatology (Oxford) (2008) 1.24
Scoring the nailfold microvascular changes during the capillaroscopic analysis in systemic sclerosis patients. Ann Rheum Dis (2007) 1.23
Monitoring adverse events of low-dose glucocorticoid therapy: EULAR recommendations for clinical trials and daily practice. Ann Rheum Dis (2010) 1.17
The molecular basis for the effectiveness, toxicity, and resistance to glucocorticoids: focus on the treatment of rheumatoid arthritis. Scand J Rheumatol (2005) 1.16
EULAR evidence-based and consensus-based recommendations on the management of medium to high-dose glucocorticoid therapy in rheumatic diseases. Ann Rheum Dis (2013) 1.14
Macrophages, synovial tissue and rheumatoid arthritis. Clin Exp Rheumatol (1993) 1.14
A review of the role of soluble fiber in health with specific reference to wheat dextrin. J Int Med Res (2009) 1.14
Esophageal baseline impedance levels in patients with pathophysiological characteristics of functional heartburn. Neurogastroenterol Motil (2014) 1.14
Oesophageal motility and bolus transit abnormalities increase in parallel with the severity of gastro-oesophageal reflux disease. Aliment Pharmacol Ther (2011) 1.12
Neuroendocrine, immunologic, and microvascular systems interactions in rheumatoid arthritis: physiopathogenetic and therapeutic perspectives. Semin Arthritis Rheum (1999) 1.11
The challenge of early systemic sclerosis for the EULAR Scleroderma Trial and Research group (EUSTAR) community. It is time to cut the Gordian knot and develop a prevention or rescue strategy. Ann Rheum Dis (2009) 1.09
Application of the platelet count/spleen diameter ratio to rule out the presence of oesophageal varices in patients with cirrhosis: a validation study based on follow-up. Dig Liver Dis (2005) 1.09
Sustained virological response to pegylated interferon and ribavirin is maintained during long-term follow-up of chronic hepatitis C patients. Aliment Pharmacol Ther (2009) 1.09
Head-to-head comparison of 1-week triple regimens combining ranitidine or omeprazole with two antibiotics to eradicate Helicobacter pylori. Aliment Pharmacol Ther (1999) 1.08
Sex hormone status in women suffering from rheumatoid arthritis. J Rheumatol (1986) 1.08
Serum cytokines and steroidal hormones in polymyalgia rheumatica and elderly-onset rheumatoid arthritis. Ann Rheum Dis (2006) 1.06
Letter: Treatment for small intestinal bacterial overgrowth--where are we now? Aliment Pharmacol Ther (2014) 1.06
Mean and median of pH values, characterizing average intragastric acidity. Am J Gastroenterol (1989) 1.06
Combined multichannel intraluminal impedance and pH-metry: a novel technique to improve detection of gastro-oesophageal reflux literature review. Dig Liver Dis (2004) 1.06
Partial regression of Barrett's esophagus by long-term therapy with high-dose omeprazole. Gastrointest Endosc (1996) 1.05
Alterations of the hypothalamic-pituitary-adrenal axis in systemic immune diseases - a role for misguided energy regulation. Clin Exp Rheumatol (2011) 1.05
Nailfold capillaroscopy and classification criteria for systemic sclerosis. Clin Exp Rheumatol (2007) 1.05
Clinical trial: the combination of rifaximin with partially hydrolysed guar gum is more effective than rifaximin alone in eradicating small intestinal bacterial overgrowth. Aliment Pharmacol Ther (2010) 1.04
Clinical trial: ulcerative colitis maintenance treatment with 5-ASA: a 1-year, randomized multicentre study comparing MMX with Asacol. Aliment Pharmacol Ther (2009) 1.03
The impact of antibiotic resistance on the efficacy of three 7-day regimens against Helicobacter pylori. Aliment Pharmacol Ther (2000) 1.02
Melatonin serum levels in rheumatoid arthritis. Ann N Y Acad Sci (2002) 1.02
Characterization of synovial fluid fibronectin from patients with rheumatic inflammatory diseases and healthy subjects. Arthritis Rheum (1984) 1.01
Evidence of cerebral hypoperfusion in scleroderma patients. Rheumatology (Oxford) (2000) 1.00
The adrenal steroid status in relation to inflammatory cytokines (interleukin-6 and tumour necrosis factor) in polymyalgia rheumatica. Rheumatology (Oxford) (2000) 1.00
Vitamin D involvement in rheumatoid arthritis and systemic lupus erythaematosus. Ann Rheum Dis (2009) 1.00
Polymyalgia rheumatica: evidence for a hypothalamic-pituitary-adrenal axis-driven disease. Clin Exp Rheumatol (2001) 0.98
Gastric aspiration versus antimony and glass pH electrodes. A simultaneous comparative in vivo study. Scand J Gastroenterol (1989) 0.98
Acid and gastric metaplasia in the duodenum. Gut (1994) 0.98
Quality of life in acute and maintenance treatment of non-erosive and mild erosive gastro-oesophageal reflux disease. Aliment Pharmacol Ther (2005) 0.98
Plasma glucose concentration in symptomatic osteoarthritis: a clinical and epidemiological survey. Clin Exp Rheumatol (1990) 0.97
No change of serum levels of leptin and adiponectin during anti-tumour necrosis factor antibody treatment with adalimumab in patients with rheumatoid arthritis. Ann Rheum Dis (2006) 0.97
Gender, body mass index and rheumatoid arthritis disease activity: results from the QUEST-RA Study. Clin Exp Rheumatol (2010) 0.97
Characteristics of joint involvement and relationships with systemic inflammation in systemic sclerosis: results from the EULAR Scleroderma Trial and Research Group (EUSTAR) database. J Rheumatol (2010) 0.96
Letter: biological therapies are effective for prevention of post-operative Crohn's disease recurrence. Aliment Pharmacol Ther (2014) 0.96
Gastric metaplasia and Helicobacter pylori infection. Gut (1995) 0.96
The process of aging changes the interplay of the immune, endocrine and nervous systems. Mech Ageing Dev (2001) 0.95
Proton pump inhibitor responders who are not confirmed as GERD patients with impedance and pH monitoring: who are they? Neurogastroenterol Motil (2013) 0.94
Monoreactive and polyreactive rheumatoid factors produced by in vitro Epstein-Barr virus-transformed peripheral blood and synovial B lymphocytes from rheumatoid arthritis patients. Scand J Immunol (1990) 0.94
Sex differences in inflammation induced cartilage damage in rodents. The influence of sex steroids. J Rheumatol (1994) 0.93
A comparison of cyclosporine, sulfasalazine, and symptomatic therapy in the treatment of psoriatic arthritis. J Rheumatol (2001) 0.93
Effect of gastric acid suppression on 13C-urea breath test: comparison of ranitidine with omeprazole. Aliment Pharmacol Ther (2000) 0.93
Contribution of germline mutations in the BRCA and PALB2 genes to pancreatic cancer in Italy. Fam Cancer (2012) 0.92
Characteristics of gastro-esophageal reflux episodes in Barrett's esophagus, erosive esophagitis and healthy volunteers. Neurogastroenterol Motil (2010) 0.92
Variability in individual response to various doses of omeprazole. Implications for antiulcer therapy. Dig Dis Sci (1994) 0.92
Preliminary results of serum androgen level testing in men with rheumatoid arthritis. Arthritis Rheum (1984) 0.92
Benefit of pregnancy in inflammatory arthritis. Ann Rheum Dis (2005) 0.92
Neuropeptides and steroid hormones in arthritis. Curr Opin Rheumatol (1998) 0.91
Italian validation of the Wagnild and Young Resilience Scale: a perspective to rheumatic diseases. Clin Exp Rheumatol (2010) 0.91
Different patterns of oesophageal acid exposure distinguish complicated reflux disease from either erosive reflux oesophagitis or non-erosive reflux disease. Aliment Pharmacol Ther (2003) 0.91
Visceral leishmaniasis infection in a rheumatoid arthritis patient treated with adalimumab. Rheumatology (Oxford) (2006) 0.91
Anti-TNF antibody treatment improves glucocorticoid induced insulin-like growth factor 1 (IGF1) resistance without influencing myoglobin and IGF1 binding proteins 1 and 3. Ann Rheum Dis (2005) 0.91
Morning symptoms in rheumatoid arthritis: a defining characteristic and marker of active disease. Scand J Rheumatol Suppl (2011) 0.90
In etanercept-treated psoriatic arthritis patients clinical improvement correlated with an increase of serum cortisol relative to other adrenal hormones. Clin Exp Rheumatol (2008) 0.89
Stool antigen assay (HpSA) is less reliable than urea breath test for post-treatment diagnosis of Helicobacter pylori infection. Aliment Pharmacol Ther (2002) 0.89
Clinical relevance of sampling rate in the characterization and analysis of 24-hour gastric acidity. A report on 413 cases. Scand J Gastroenterol (1989) 0.89